1-6469122-TTCCTCCTCCTCCTCCTCC-TTCCTCCTCCTCC
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_020631.6(PLEKHG5):c.2163_2168delGGAGGA(p.Glu722_Glu723del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00862 in 1,588,674 control chromosomes in the GnomAD database, including 99 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. E721DEQEEEEEEEEEE) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.014 ( 35 hom., cov: 31)
Exomes 𝑓: 0.0081 ( 64 hom. )
Consequence
PLEKHG5
NM_020631.6 disruptive_inframe_deletion
NM_020631.6 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.94
Genes affected
PLEKHG5 (HGNC:29105): (pleckstrin homology and RhoGEF domain containing G5) This gene encodes a protein that activates the nuclear factor kappa B (NFKB1) signaling pathway. Mutations in this gene are associated with autosomal recessive distal spinal muscular atrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-6469122-TTCCTCC-T is Benign according to our data. Variant chr1-6469122-TTCCTCC-T is described in ClinVar as [Benign]. Clinvar id is 194977.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-6469122-TTCCTCC-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.014 (2041/145478) while in subpopulation AFR AF= 0.0316 (1126/35584). AF 95% confidence interval is 0.0301. There are 35 homozygotes in gnomad4. There are 1017 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 35 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLEKHG5 | NM_020631.6 | c.2163_2168delGGAGGA | p.Glu722_Glu723del | disruptive_inframe_deletion | 19/21 | ENST00000377728.8 | NP_065682.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLEKHG5 | ENST00000377728.8 | c.2163_2168delGGAGGA | p.Glu722_Glu723del | disruptive_inframe_deletion | 19/21 | 2 | NM_020631.6 | ENSP00000366957.3 |
Frequencies
GnomAD3 genomes AF: 0.0140 AC: 2037AN: 145374Hom.: 35 Cov.: 31
GnomAD3 genomes
AF:
AC:
2037
AN:
145374
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0115 AC: 2258AN: 196576Hom.: 17 AF XY: 0.0110 AC XY: 1178AN XY: 106916
GnomAD3 exomes
AF:
AC:
2258
AN:
196576
Hom.:
AF XY:
AC XY:
1178
AN XY:
106916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00808 AC: 11658AN: 1443196Hom.: 64 AF XY: 0.00801 AC XY: 5753AN XY: 718176
GnomAD4 exome
AF:
AC:
11658
AN:
1443196
Hom.:
AF XY:
AC XY:
5753
AN XY:
718176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0140 AC: 2041AN: 145478Hom.: 35 Cov.: 31 AF XY: 0.0143 AC XY: 1017AN XY: 71126
GnomAD4 genome
AF:
AC:
2041
AN:
145478
Hom.:
Cov.:
31
AF XY:
AC XY:
1017
AN XY:
71126
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 31, 2015 | - - |
Neuronopathy, distal hereditary motor, autosomal recessive 4;C3809309:Charcot-Marie-Tooth disease recessive intermediate C Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
PLEKHG5-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 04, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at